New Study Examines Long-Term
Impact of TPT
Posted on: Friday 16th October, 2026


A major new study published in The Lancet Respiratory Medicine, co-authored by Chief Investigators Associate Professor Sarah Bernays and Professor Guy Marks, has found that tuberculosis preventive treatment (TPT) provides strong protection against developing TB among people with latent TB infection who have been exposed to a person with tuberculosis.
Researchers analysed data from more than 84,000 people across 44 studies in 24 countries. They found that TPT offered long-lasting protection in low- and medium-burden settings, reducing TB risk for at least 13 years and 8 years respectively. In high-burden settings, however, the protective effect declined within around one year, likely due to ongoing exposure and reinfection.
The findings reinforce the value of providing TPT to people at high risk of TB, particularly household contacts of people with tuberculosis. The authors conclude that while TPT remains a powerful prevention tool, it should be combined with broader TB control measures in high-burden settings to achieve sustained long-term impact.
